Status:
COMPLETED
V501 Efficacy Study in Women Aged 18 to 26 (V501-027)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
HPV Infections
Eligibility:
FEMALE
18-26 years
Phase:
PHASE2
Brief Summary
A study to evaluate the efficacy, immunogenicity, safety and tolerability of V501 in adult women
Eligibility Criteria
Inclusion
- Female Subject Aged 18 To 26 Years
- With 1-4 Lifetime Sexual Partners
Exclusion
- Male Subject
Key Trial Info
Start Date :
June 12 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 16 2009
Estimated Enrollment :
1021 Patients enrolled
Trial Details
Trial ID
NCT00378560
Start Date
June 12 2006
End Date
September 16 2009
Last Update
April 17 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.